Latest Seeds News

Page 2 of 15
Elixinol Wellness has lifted combined hemp sales 12% to $6.41 million in the first nine months of 2026, while unaudited gross profit rose 41%. Two major grocery programs are now fully supplied through 2027, with Hemp Gold Protein due back at Costco in Australia and New Zealand.
Victor Sage
Victor Sage
13 Oct 2026
Australian Ethical Investment delivered record funds under management and a 29% rise in shareholder profit in FY26, despite weak performance from Australian equities and emerging companies. The ASX-listed ethical fund manager also increased its fully franked dividend and set out a growth plan centred on private markets, superannuation and technology.
Claire Turing
Claire Turing
9 Oct 2026
Wide Open Agriculture has completed a study for a proposed 10,000-tonne-per-year lupin protein facility with indicative annual revenue of A$240 million to A$295 million. The project remains unfunded, unapproved and years from production, leaving contract manufacturing as the immediate test of the company’s strategy.
Victor Sage
Victor Sage
6 Oct 2026
Nufarm is pairing a narrower crop-protection portfolio with heavier investment in seeds and tighter capital controls as it targets A$370 million to A$380 million in FY26 underlying EBITDA. The company has reaffirmed positive free cash flow, leverage of about 2.0 times and a A$50 million cost-saving program due to reach run-rate by the end of FY27.
Ada Torres
Ada Torres
28 Sept 2026
Financial Income Fund delivered a 6.78% net return in the year to 30 June 2026, beating its hybrid securities benchmark by 0.92 percentage points. The audited report also records the launch of an ETF class, higher distributions and a shift away from convertible notes.
Victor Sage
Victor Sage
24 Sept 2026
Globe Metals & Mining has completed compensation payments to all 203 households affected by Phase 1 of its Kanyika niobium project in Malawi, clearing a major land-access milestone. The company now targets initial pit opening, mining and stockpiling in the coming weeks, while relocation and cultural heritage work remain unfinished.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Nufarm expects FY26 underlying EBITDA to rise about 25% at the midpoint of its $370 million to $380 million range, while leverage falls from 2.7 times to approximately 2.0 times. The improvement comes alongside a sweeping cost-reduction program, but restructuring charges of up to $110 million post tax remain in the numbers.
Ada Torres
Ada Torres
23 Sept 2026
Booster Innovation Fund has invested $200,000 in TheiaNova, a University of Auckland spinout developing a self-administered eye drop for keratoconus. The seed-stage bet accounts for 0.76% of BIF’s portfolio, keeping the exposure modest while adding an early biotechnology asset.
Ada Torres
Ada Torres
22 Sept 2026
Iron Road’s largest shareholder has distributed its remaining 59.72% stake just as the company prepares to restart delayed nickel-copper-gold drilling at Irria. The transition also includes the November retirement of long-serving chief executive Larry Ingle, with no successor named.
Maxwell Dee
Maxwell Dee
22 Sept 2026
MA Financial has agreed to buy a 50% interest in Melbourne’s The Glen Shopping Centre for $327.5 million while launching a fund targeting more than $500 million of large format retail assets. The transactions lift its retail property activity in the second half of 2026 to $500 million.
Victor Sage
Victor Sage
17 Sept 2026
Scalare Partners has swung to positive EBITDA as acquisitions of Tank Stream Labs and Planet Startup lifted FY26 total income 411% to $17.9 million. The startup investor remains loss-making after sharply higher depreciation, amortisation and financing costs, while its portfolio reached $12.5 million across 25 companies.
Victor Sage
Victor Sage
15 Sept 2026
JPMorgan Equity Premium Income ETF reported a sharp fall in operating profit as fair-value losses overwhelmed higher distribution income. The fund will also switch its underlying ETF from NYSE Arca to a London-listed vehicle, while keeping its stated investment objective and total management fees and costs unchanged.
Claire Turing
Claire Turing
15 Sept 2026

Browse the archive

Full archive